Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crystal L Mackall

Showing results (171-180 of 232) with videos related to

Pageof 24
Sort By:
Cancer Discovery|March 21, 2020
Tuning the Antigen Density Requirement for CAR T-cell ActivityRobbie G Majzner, Skyler P Rietberg, Elena Sotillo, et al.
The Journal of Experimental Medicine|June 25, 2008
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsetsClaude Sportès, Frances T Hakim, Sarfraz A Memon, et al.
Nature Medicine|April 6, 2023
Tumor inflammation-associated neurotoxicityJasia Mahdi, Jorg Dietrich, Karin Straathof, et al.
Science (New York, N.Y.)|November 10, 2022
Enhanced T cell effector activity by targeting the Mediator kinase moduleKatherine A Freitas, Julia A Belk, Elena Sotillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPETFederico Simonetta, Israt S Alam, Juliane K Lohmeyer, et al.
Cell Reports. Medicine|January 21, 2026
c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumorsHyatt Balke-Want, Vimal Keerthi, Maria Del Carmen Arenas, et al.
Blood Advances|February 11, 2021
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphomaJohn H Baird, David J Epstein, John S Tamaresis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1Paul F Robbins, Richard A Morgan, Steven A Feldman, et al.
Cancer Discovery|June 13, 2018
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 <sup>c259</sup>T Cells in Synovial SarcomaSandra P D'Angelo, Luca Melchiori, Melinda S Merchant, et al.
Cell|April 28, 2022
Enhanced safety and efficacy of protease-regulated CAR-T cell receptorsLouai Labanieh, Robbie G Majzner, Dorota Klysz, et al.
Pageof 24

Showing results (171-180 of 232) with videos related to

Sort By:
Pageof 24
Cancer Discovery|March 21, 2020
Tuning the Antigen Density Requirement for CAR T-cell ActivityRobbie G Majzner, Skyler P Rietberg, Elena Sotillo, et al.
The Journal of Experimental Medicine|June 25, 2008
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsetsClaude Sportès, Frances T Hakim, Sarfraz A Memon, et al.
Nature Medicine|April 6, 2023
Tumor inflammation-associated neurotoxicityJasia Mahdi, Jorg Dietrich, Karin Straathof, et al.
Science (New York, N.Y.)|November 10, 2022
Enhanced T cell effector activity by targeting the Mediator kinase moduleKatherine A Freitas, Julia A Belk, Elena Sotillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPETFederico Simonetta, Israt S Alam, Juliane K Lohmeyer, et al.
Cell Reports. Medicine|January 21, 2026
c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumorsHyatt Balke-Want, Vimal Keerthi, Maria Del Carmen Arenas, et al.
Blood Advances|February 11, 2021
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphomaJohn H Baird, David J Epstein, John S Tamaresis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1Paul F Robbins, Richard A Morgan, Steven A Feldman, et al.
Cancer Discovery|June 13, 2018
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 <sup>c259</sup>T Cells in Synovial SarcomaSandra P D'Angelo, Luca Melchiori, Melinda S Merchant, et al.
Cell|April 28, 2022
Enhanced safety and efficacy of protease-regulated CAR-T cell receptorsLouai Labanieh, Robbie G Majzner, Dorota Klysz, et al.
Pageof 24